Royal Phillips
-
Exor raises stake cap in Royal Philips to 22% in updated agreement
Under the revised agreement, Exor can raise its shareholding in Philips to up to 22% of the company’s issued ordinary share capital and voting rights, compared with the previous 20% limit.
-
Philips expands connected patient monitoring ecosystem with six technology partnerships
The partnerships will enable healthcare providers to integrate wearable and out-of-hospital monitoring technologies into the Philips ecosystem.
-
Philips secures FDA 510(k) clearance for next-generation reusable SpO₂ clip sensor
The new reusable sensor features internal optical refinements that improve signal quality and measurement consistency.
-
Philips obtains FDA approval for Elevate Plus AI ultrasound enhancement
The newly cleared technology aims to standardize routine ultrasound examinations, reduce variability between operators, and minimize the need for repeat scans.
-
Philips launches FDA-cleared Rembra platform for high-throughput imaging
The Rembra platform extends the use of computed tomography beyond traditional diagnostic radiology into radiation therapy planning.
-
Royal Philips appoints Marc Zora as new CEO for META region
Zora brings a wealth of experience from his 15-year journey within Philips, during which he has established himself as a trusted leader across multiple markets in the region.